FDA 483 - Dynavax GmbH

Dynavax GmbH, a bulk drug substance manufacturer in Dusseldorf, Germany, was inspected by the FDA from January 26 to February 03, 2023. The inspection revealed one observation concerning inadequate investigations into out-of-specification test results. Specifically, the firm failed to adequately review the sanitization processes of manufacturing equipment during these investigations.